SG10201609137PA - Gamma-polyglutamic acid and zinc compositions - Google Patents
Gamma-polyglutamic acid and zinc compositionsInfo
- Publication number
- SG10201609137PA SG10201609137PA SG10201609137PA SG10201609137PA SG10201609137PA SG 10201609137P A SG10201609137P A SG 10201609137PA SG 10201609137P A SG10201609137P A SG 10201609137PA SG 10201609137P A SG10201609137P A SG 10201609137PA SG 10201609137P A SG10201609137P A SG 10201609137PA
- Authority
- SG
- Singapore
- Prior art keywords
- polyglutamic acid
- gamma
- compositions
- zinc
- zinc compositions
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 4
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 title abstract 3
- 229920002643 polyglutamic acid Polymers 0.000 title abstract 3
- 239000011701 zinc Substances 0.000 title abstract 3
- 229910052725 zinc Inorganic materials 0.000 title abstract 3
- 235000015872 dietary supplement Nutrition 0.000 abstract 2
- 239000002775 capsule Substances 0.000 abstract 1
- 239000008297 liquid dosage form Substances 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 239000007909 solid dosage form Substances 0.000 abstract 1
- 150000003751 zinc Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/785—Polymers containing nitrogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/30—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
- A23L33/165—Complexes or chelates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
- A61K31/315—Zinc compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/645—Polycationic or polyanionic oligopeptides, polypeptides or polyamino acids, e.g. polylysine, polyarginine, polyglutamic acid or peptide TAT
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6921—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
- A61K9/2045—Polyamides; Polyaminoacids, e.g. polylysine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Inorganic Chemistry (AREA)
- Nutrition Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Mycology (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Physiology (AREA)
- Molecular Biology (AREA)
- Neurosurgery (AREA)
- Immunology (AREA)
- Neurology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Gynecology & Obstetrics (AREA)
- Dispersion Chemistry (AREA)
- Zoology (AREA)
- Dermatology (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Psychology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (16)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SG10201609137PA SG10201609137PA (en) | 2016-11-01 | 2016-11-01 | Gamma-polyglutamic acid and zinc compositions |
SG11201903732TA SG11201903732TA (en) | 2016-11-01 | 2017-10-31 | Gamma-polyglutamic acid and zinc compositions |
US16/346,283 US20190247428A1 (en) | 2016-11-01 | 2017-10-31 | Gamma-polyglutamic acid and zinc compositions |
MX2019005103A MX2019005103A (es) | 2016-11-01 | 2017-10-31 | Composiciones de acido gamma-poliglutamico y zinc. |
DK17809399.3T DK3534915T3 (da) | 2016-11-01 | 2017-10-31 | Gamma-polyglutaminsyre og zinksammensætninger |
ES17809399T ES2969208T3 (es) | 2016-11-01 | 2017-10-31 | Composiciones de ácido gamma-poliglutámico y zinc |
JP2019545868A JP2019534046A (ja) | 2016-11-01 | 2017-10-31 | ガンマ−ポリグルタミン酸および亜鉛組成物 |
EP17809399.3A EP3534915B1 (de) | 2016-11-01 | 2017-10-31 | Gamma-polyglutaminsäure und zink präparate |
AU2017354786A AU2017354786B2 (en) | 2016-11-01 | 2017-10-31 | Gamma-polyglutamic acid and zinc compositions |
KR1020197015742A KR20190122203A (ko) | 2016-11-01 | 2017-10-31 | 감마-폴리글루탐산 및 아연 조성물 |
PCT/SG2017/050544 WO2018084805A1 (en) | 2016-11-01 | 2017-10-31 | Gamma-polyglutamic acid and zinc compositions |
CA3042234A CA3042234A1 (en) | 2016-11-01 | 2017-10-31 | Gamma-polyglutamic acid and zinc compositions |
CN201711096131.4A CN108014130A (zh) | 2016-11-01 | 2017-11-01 | γ-聚谷氨酸和锌的组合物 |
MX2022013541A MX2022013541A (es) | 2016-11-01 | 2019-04-30 | Composiciones de acido gamma-poliglutamico y zinc. |
JP2022144662A JP2023016043A (ja) | 2016-11-01 | 2022-09-12 | ガンマ-ポリグルタミン酸および亜鉛組成物 |
AU2023203216A AU2023203216A1 (en) | 2016-11-01 | 2023-05-23 | Gamma-polyglutamic acid and zinc compositions |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SG10201609137PA SG10201609137PA (en) | 2016-11-01 | 2016-11-01 | Gamma-polyglutamic acid and zinc compositions |
Publications (1)
Publication Number | Publication Date |
---|---|
SG10201609137PA true SG10201609137PA (en) | 2018-06-28 |
Family
ID=60582642
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG10201609137PA SG10201609137PA (en) | 2016-11-01 | 2016-11-01 | Gamma-polyglutamic acid and zinc compositions |
SG11201903732TA SG11201903732TA (en) | 2016-11-01 | 2017-10-31 | Gamma-polyglutamic acid and zinc compositions |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201903732TA SG11201903732TA (en) | 2016-11-01 | 2017-10-31 | Gamma-polyglutamic acid and zinc compositions |
Country Status (12)
Country | Link |
---|---|
US (1) | US20190247428A1 (de) |
EP (1) | EP3534915B1 (de) |
JP (2) | JP2019534046A (de) |
KR (1) | KR20190122203A (de) |
CN (1) | CN108014130A (de) |
AU (2) | AU2017354786B2 (de) |
CA (1) | CA3042234A1 (de) |
DK (1) | DK3534915T3 (de) |
ES (1) | ES2969208T3 (de) |
MX (2) | MX2019005103A (de) |
SG (2) | SG10201609137PA (de) |
WO (1) | WO2018084805A1 (de) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102094182B1 (ko) * | 2018-06-28 | 2020-03-30 | 주식회사 알랙스탠드 | 아연 함유 수용성 폴리글루타믹산 복합체 조성물 |
CN117224690B (zh) * | 2023-11-10 | 2024-01-30 | 江苏海王健康生物科技有限公司 | 一种作为助剂的γ-聚谷氨酸混合物、组合物、制备方法 |
Family Cites Families (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2712583B2 (ja) * | 1989-06-28 | 1998-02-16 | 味の素株式会社 | 易吸収性ミネラル含有飲食物 |
JP3232718B2 (ja) * | 1992-03-24 | 2001-11-26 | 味の素株式会社 | 易吸収性ミネラル含有組成物及びそれを含有する飲食品 |
JP3551149B2 (ja) * | 1992-03-24 | 2004-08-04 | 味の素株式会社 | 易吸収性ミネラル含有組成物及びそれを含有する飲食品 |
US5447732A (en) * | 1992-11-25 | 1995-09-05 | Ajinomoto Co., Inc. | High-absorption mineral-containing composition and foods |
ITMI950515A0 (it) * | 1995-03-16 | 1995-03-16 | Valpharma Sa | Formulazioni gastroresistenti contenenti zinco |
JPH11313618A (ja) * | 1998-05-06 | 1999-11-16 | Yoshio Inoue | 胃にやさしい家畜用ミネラル(亜鉛)製剤及びその製造法 |
WO2004080210A1 (en) * | 2003-03-14 | 2004-09-23 | Boehringer Ingelheim Danmark A/S | Compositions of dietary metals for support of the physiological intestinal development and prevention of diarrhoea |
JP4457641B2 (ja) * | 2003-11-10 | 2010-04-28 | 味の素株式会社 | ゼラチンカプセル |
JP5162812B2 (ja) * | 2004-07-08 | 2013-03-13 | 大正製薬株式会社 | 亜鉛含有経口投与用組成物 |
JPWO2007043606A1 (ja) * | 2005-10-12 | 2009-04-16 | 株式会社ジェノラックBl | アニオン性ポリアミノ酸/金属複合体からなる抗糖尿病薬剤 |
CA2756942C (en) * | 2009-04-10 | 2019-01-08 | Cypress Pharmaceuticals, Inc. | Phosphate-binding magnesium salts and uses thereof |
JO3635B1 (ar) * | 2009-05-18 | 2020-08-27 | Millennium Pharm Inc | مركبات صيدلانية صلبة وطرق لانتاجها |
CN101692851B (zh) * | 2009-10-20 | 2014-01-08 | 华中农业大学 | γ-聚谷氨酸或其盐类作为添加剂在乳制品中的应用 |
CN101716180B (zh) * | 2009-11-06 | 2013-04-24 | 广西强寿药业集团有限公司 | 一种组合补充锌、钙药物及其制备方法 |
AU2011225810B2 (en) * | 2010-03-10 | 2014-11-06 | Lupin Limited | Rifaximin ready-to-use suspension |
UA110853C2 (uk) * | 2011-09-13 | 2016-02-25 | Фармасайклікс, Інк. | Лікарські форми інгібітора гістондеацетилази у комбінації з бендамустином та їхнє застосування |
EP2922557B1 (de) * | 2012-11-21 | 2017-10-04 | KBS Research, LLC | Pflanzliche zusätze und verfahren zur verwendung davon |
TWI660748B (zh) * | 2013-03-01 | 2019-06-01 | 日商大塚製藥股份有限公司 | 用於口服投藥之包含非晶型托伐普坦(Tolvaptan)的懸浮液 |
CN103690521B (zh) * | 2013-11-29 | 2016-07-06 | 湖北福人金身药业有限公司 | 一种葡萄糖酸钙锌口服溶液 |
JP2016069303A (ja) * | 2014-09-29 | 2016-05-09 | タカラバイオ株式会社 | フコイダンを有効成分とする脱毛抑制用組成物 |
DK3006045T3 (en) * | 2014-10-07 | 2017-07-17 | Cyprumed Gmbh | Pharmaceutical formulations for oral administration of peptide or protein drugs |
JP6672277B2 (ja) * | 2014-10-08 | 2020-04-01 | シンセティック・バイオロジクス・インコーポレイテッド | ベータラクタマーゼ製剤およびその使用 |
WO2016088816A1 (ja) * | 2014-12-03 | 2016-06-09 | ノーベルファーマ株式会社 | 酢酸亜鉛水和物錠及びその製造方法 |
-
2016
- 2016-11-01 SG SG10201609137PA patent/SG10201609137PA/en unknown
-
2017
- 2017-10-31 WO PCT/SG2017/050544 patent/WO2018084805A1/en unknown
- 2017-10-31 ES ES17809399T patent/ES2969208T3/es active Active
- 2017-10-31 MX MX2019005103A patent/MX2019005103A/es unknown
- 2017-10-31 JP JP2019545868A patent/JP2019534046A/ja active Pending
- 2017-10-31 KR KR1020197015742A patent/KR20190122203A/ko not_active Application Discontinuation
- 2017-10-31 US US16/346,283 patent/US20190247428A1/en active Pending
- 2017-10-31 CA CA3042234A patent/CA3042234A1/en active Pending
- 2017-10-31 EP EP17809399.3A patent/EP3534915B1/de active Active
- 2017-10-31 AU AU2017354786A patent/AU2017354786B2/en active Active
- 2017-10-31 DK DK17809399.3T patent/DK3534915T3/da active
- 2017-10-31 SG SG11201903732TA patent/SG11201903732TA/en unknown
- 2017-11-01 CN CN201711096131.4A patent/CN108014130A/zh active Pending
-
2019
- 2019-04-30 MX MX2022013541A patent/MX2022013541A/es unknown
-
2022
- 2022-09-12 JP JP2022144662A patent/JP2023016043A/ja active Pending
-
2023
- 2023-05-23 AU AU2023203216A patent/AU2023203216A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
KR20190122203A (ko) | 2019-10-29 |
AU2017354786A1 (en) | 2019-05-16 |
JP2019534046A (ja) | 2019-11-28 |
AU2017354786B2 (en) | 2023-02-23 |
CA3042234A1 (en) | 2018-05-11 |
EP3534915B1 (de) | 2023-12-20 |
US20190247428A1 (en) | 2019-08-15 |
MX2019005103A (es) | 2019-10-30 |
EP3534915A1 (de) | 2019-09-11 |
ES2969208T3 (es) | 2024-05-17 |
AU2023203216A1 (en) | 2023-06-22 |
CN108014130A (zh) | 2018-05-11 |
SG11201903732TA (en) | 2019-05-30 |
JP2023016043A (ja) | 2023-02-01 |
MX2022013541A (es) | 2022-11-16 |
WO2018084805A1 (en) | 2018-05-11 |
DK3534915T3 (da) | 2024-01-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12017500802B1 (en) | Hydroxyalkyl-substituted phenyltriazole derivatives and uses thereof | |
ZA201405101B (en) | "new indolizine compounds, a process for their preparation and pharmaceutical compositions containing them." | |
WO2015165413A8 (zh) | 一种新型的稳定型抗体药物耦联物及其制备方法和用途 | |
PH12016502463A1 (en) | Bi-layer dual release probiotic tablets | |
WO2014180889A8 (en) | Methods and compositions for the treatment of cancer | |
MX2016016995A (es) | Composiciones de acido fitico, magnesio y polifenoles y su aplicacion para la prevencion de la litiasis renal oxalocalcica. | |
IL272806A (en) | The history of boronic acid, its preparation and pharmaceutical preparations containing it | |
IL280376A (en) | The history of boronic acid, its preparation and pharmaceutical preparations containing it | |
IL228265A (en) | History of pyrido {b – 2,3} pyrazine, their preparation and their pharmaceutical preparations | |
MX2014012164A (es) | Composiciones a base de probioticos y un complejo de polen de abejas/arcilla, su preparacion y sus usos en nutricion y en terapeutica. | |
HUE049298T2 (hu) | Szitagliptin tartalmú stabil gyógyszerészeti készítmények azonnali hatóanyag leadású tabletta formájában | |
MX2022013541A (es) | Composiciones de acido gamma-poliglutamico y zinc. | |
WO2016080796A3 (ko) | 세스퀴테르펜 화합물을 포함하는, stat3 매개 질환의 예방 또는 치료용 약학적 조성물 및 이의 용도 | |
PH12015501377A1 (en) | Solid unit with high fexofenadine content and process for the preparation thereof | |
HK1214600A1 (zh) | 種含磷吡啶並 嘧啶- -酮類化合物或其藥學上可接受的鹽、藥物組合物及其應用 | |
PH12017501243A1 (en) | Oral delivery product | |
ZA201607245B (en) | Maternal vitamin b2 administration for the prevention of increased adiposity, overweight or obesity in the offspring | |
WO2015022560A8 (en) | Stable pharmaceutical composition containing bisoprolol and ramipril | |
WO2014049566A3 (en) | Nutritional kit | |
UA92914U (uk) | Антиоксидантний та імуномодулюючий препарат "селцивіт" | |
WO2013127539A3 (de) | Pharmazeutische formulierung enthaltend flupirtin | |
GR1008442B (el) | Φαρμακευτικο σκευασμα περιεχον αριπιπραζολη ή αλας αυτης | |
EP2796130A3 (de) | Tabletten mit unmittelbarer Freisetzung von Rasagilin Hemitartrate | |
RU2011132300A (ru) | Способ профилактики преждевременного старения организма человека | |
UA100812U (uk) | Вітамінно-мінеральний препарат пролонгованої дії "вітармін" |